Cellebrite DI Ltd. income statement

In fiscal 2025, Cellebrite DI Ltd. reported revenue of $476m, up 18.6% on the year before, operating income of $66.5m (a 14.0% margin) and net income of $78.3m, or $0.31 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Cellebrite DI Ltd.: income statement, annual
Fiscal year	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Revenue	172	195	246	271	325	401	476
Cost of revenue	36	38	43	51	53	63	75
Gross profit	136	157	204	220	272	339	401
Research and development	47	54	66	81	84	98	114
Selling and marketing	62	61	76	97	111	132	155
General and administrative	29	32	48	41	43	51	65
Operating income	−2	9	14	1	33	57	66
Income before tax	1	11	82	121	−76	−276	91
Income tax	3	6	11	−0	6	7	12
Net income	−2	6	71	121	−81	−283	78
Diluted EPS	−$0.08	−$0.08	$0.44	$0.59	−$0.43	−$1.35	$0.31
Diluted shares (average)	122m	124m	162m	195m	190m	209m	250m
EBITDA	3	15	21	10	43	68	78

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: ADEA vs CLBT CLBT vs SPT AVPT vs CLBT

More: Application Software stocks compared, Technology sector, rankings of US companies

Figures from Cellebrite DI Ltd.'s SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Cellebrite DI Ltd.